X

Career opportunities at Envigo

If you would like to become part of the team that shapes our future, then visit our careers portal for our current vacancies. Learn more

Explore our Envigo blog

Bringing you the latest thinking and insights to help you reach your critical milestones. Visit our blog

Press release

Avista Healthcare Public Acquisition Corp., a publicly traded special purpose acquisition company, and Envigo International Holdings, Inc., a leading early stage non-clinical contract research organization offering a diverse set of non-clinical discovery and safety assessment services as well as laboratory animal science tools, jointly announced that they have entered into a definitive merger agreement. Read more

New appointment of business lead consultant strengthens regulatory consultancy

The company’s unique shopfull service offering for regulatory advice and research bolstered by optimized consulting expertise Read More

Envigo appoints Chief Commercial Officer and President of EMEA Operations

Envigo announced today that it has made two new appointments to its Executive Committee. The appointments of a Chief Commercial Officer and President of EMEA Operations have been made at a time of growth for Envigo during which the organization has been focused on improving the quality of the customer experience for its global customer base. Read More

Envigo’s Gary Dean appointed to prestigious IUPAC 2019 organizing committee

Envigo is pleased to announce the appointment of Business Lead Consultant – Crop Protection, Gary Dean, to the organising committee of IUPAC International Congress of Crop Protection Chemistry congress 2019. Read More

See All Latest News
Brochure
Envigo oncology brochure (USA | EU)

At Envigo, we understand that our customers conduct research and develop products that have the potential to offer significant improvements to global health and the environment. We also realize achieving that potential has grown more challenging. That is why we remain focused on your goals, needs and expectations, ensuring you have a trusted partner to advance your life-changing research and products.

Article
Developments in LifeSciences Vol. 15, No. 1

In this issue:
• 20 critical questions for ensuring inhaled crop protection and chemical registration
• The CRO landscape — An evolving safety testing market
• Substance identity: The critical component of both lead and co-registrant dossiers
• The extended one-generation reproductive toxicity study (EOGRTS), OECD test guideline 443

Webinar on-demand
Key considerations in the safety evaluation of drugs targeting immune checkpoints

Presented by Lee Coney (Chief Scientific Officer - Biologics) and Mandy Horn (Supervisor - Veterinary Science, Research and Support). You will learn what is cancer immunotherapy; what are the potential challenges in the safety assessment of antibodies targeting immune system checkpoints?; Things to consider when designing and running your nonclinical safety programmes for immune checkpoint targets; and more.

See all insights